Technology | Radiation Dose Management | April 04, 2019

Omega Medical Imaging Launches AI-enabled FluoroShield for Radiation Reduction

System combines AI, ultra-fast collimator and advanced image processing to reduce radiation exposure for interventional X-ray imaging

April 4, 2019 — The U.S. Food and Drug Administration (FDA) granted Omega Medical Imaging 510(k) clearance to offer their artificial intelligence (AI)-powered region of interest (ROI) radiation exposure reduction solution FluoroShield for interventional X-ray imaging on their flat panel detector CS-series product lines.

FluoroShield combines AI, an ultra-fast collimator and advanced image processing to deliver an ROI solution that has shown to reduce radiation exposure up to approximately 84 percent. The AI helps minimize X-ray dose to patients and staff while TruBlock technology completely blocks radiation. This delivers maximum radiation reduction while optimizing workflow, helping interventional clinicians better reach their ALARA (as low as reasonably achievable) goals.

For more information: www.omegamedicalimaging.com

Related Content

The key trends Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at the 2020 Radiological Society of North America (RSNA) meeting. Getty Imagesbserved at 2020 Radiological Society of North America (RSNA) meeting all focused around COVID-19 (SARS-CoV-2) and the impact it has had on radiology. #RSNA #RSNA20 #RSNA2020

Clinicians reviewing a COVID-19 patient's lung CT that reveals the severity of COVID-caused pneumonia. The impact of COVID on radiology was a major, over arching trend at the 2020 Radiological Society of North America (RSNA) meeting. Getty Images

Feature | RSNA | January 20, 2021 | By Melinda Taschetta-Millane and Dave Fornell

Top Trend Takeaways in Radiology From RSNA 2020

new study published on European Radiology evaluates the image quality of low iodine concentration, dual-energy CT (DECT) combined with a deep learning–based denoising technique with ClariCT.AI for pediatric abdominal CT, compared with that of standard iodine concentration single-energy polychromatic CT (SECT).

News | Artificial Intelligence | January 19, 2021

New Study Shows Value of Low-concentration Iodine When Paired with Dual-Energy CT and DL Technique

January 19, 2021 —

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Angiography | January 19, 2021 | By Bhvita Jani

Interventional Mobile C-arm and Angiography Markets Plummeted Amid COVID-19

January 19, 2021 – With the postponement of non-essential elective surgeries and medical procedures in 2020 to conser

AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient care, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the company’s flagship image analysis platform.

News | Artificial Intelligence | January 18, 2021

AI Metrics Receives FDA Clearance For Imaging Software

January 18, 2021 — AI Metrics, LLC, a medical imaging startup focused on augmented intelligence to improve patient ca

This cutting-edge technology assists radiologists in the interpretation of screening mammograms and allows them to diagnose breast cancer earlier and more accurately

News | Mammography | January 12, 2021

Therapixel receives CE mark for AI-based software MammoScreen

January 12, 2021 — Therapixel announced that...

The U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.

News | Artificial Intelligence | January 12, 2021

FDA Releases AI/Machine Learning Action Plan

January 12, 2021 — The U.S.

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site. #AI #AIhealthcare #AIecho

Ultromics will offer its artificial intelligence driven EchoGo Pro as a stress-echo module in the EchoGo suite alongside EchoGo Core, its AI solution for automated systolic function and strain analysis. The EchoGo suite is a cloud-based service that uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.

News | Artificial Intelligence | January 06, 2021

FDA Clears Ultromics Echocardiography AI for Auto Identification of Coronary Artery Disease

January 6, 2021 — The U.S.